Skip to main content
Log in

Insomnia disorder and cancer mortality in South Korea: a secondary analysis of musculoskeletal disease cohort

  • Sleep Breathing Physiology and Disorders • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Purpose

The association between insomnia disorder and cancer-related mortality risk remains controversial. Therefore, this study aimed to investigate the correlation between insomnia disorder and cancer-related mortality.

Methods

Patients who were diagnosed with musculoskeletal disease (MSD) between 2010 and 2015 were included in this study as a secondary analysis of a patient cohort with MSD in South Korea. Cancer mortality was evaluated between January 1, 2016, and December 31, 2020, using multivariable Cox regression modeling. Patients with and without insomnia disorder constituted the ID and non-ID groups, respectively.

Results

The final analysis incorporated a total of 1,298,314 patients diagnosed with MSDs, of whom 11,714 (0.9%) died due to cancer. In the multivariable Cox regression model, the risk of total cancer-related mortality was 14% (hazard ratio [HR], 1.14; 95% confidence interval [CI], 1.10–1.19; P < 0.001) higher in the ID group than in the non-ID group. Moreover, the ID group had a higher risk of mortality due to esophageal (HR, 1.46; 95% CI, 1.08–1.96; P = 0.015), colorectal (HR, 1.20; 95% CI, 1.05–1.36; P = 0.007), head and neck (HR, 1.39; 95% CI, 1.01–1.94; P = 0.049), lung (HR, 1.17; 95% CI, 1.08–1.27; P < 0.001), and female genital organ (HR: 1.39, 95% CI: 1.09, 1.77; P = 0.008) cancers; leukemia; and lymphoma (HR, 1.30; 95% CI, 1.12–1.49; P < 0.001).

Conclusion

Insomnia disorder was associated with elevated overall cancer mortality in patients with MSDs, which was more evident for cancer mortality due to esophageal, colorectal, head and neck, lung, and female genital organ cancers; leukemia; and lymphoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Data will be available upon reasonable request to the corresponding author.

References

  1. Global Burden of Disease Cancer C, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA et al (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol 3(4):524–48. https://doi.org/10.1001/jamaoncol.2016.5688

  2. Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD et al (2022) Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol 8(3):420–444

    Article  PubMed  Google Scholar 

  3. Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA: Cancer J Clin 72(1):7–33

  4. Dalmartello M, La Vecchia C, Bertuccio P, Boffetta P, Levi F, Negri E et al (2022) European cancer mortality predictions for the year 2022 with focus on ovarian cancer. Ann Oncol 33(3):330–339

    Article  CAS  PubMed  Google Scholar 

  5. Winkelman JW (2015) Insomnia disorder. N Engl J Med 373(15):1437–1444

    Article  CAS  PubMed  Google Scholar 

  6. Fang H-F, Miao N-F, Chen C-D, Sithole T, Chung M-H (2015) Risk of cancer in patients with insomnia, parasomnia, and obstructive sleep apnea: a nationwide nested case-control study. J Cancer 6(11):1140–1147

    Article  PubMed  PubMed Central  Google Scholar 

  7. Shi T, Min M, Sun C, Zhang Y, Liang M, Sun Y (2020) Does insomnia predict a high risk of cancer? A systematic review and meta-analysis of cohort studies. J Sleep Res 29(1):e12876

    Article  PubMed  Google Scholar 

  8. Ge L, Guyatt G, Tian J, Pan B, Chang Y, Chen Y et al (2019) Insomnia and risk of mortality from all-cause, cardiovascular disease, and cancer: systematic review and meta-analysis of prospective cohort studies. Sleep Med Rev 48:101215. https://doi.org/10.1016/j.smrv.2019.101215

    Article  PubMed  Google Scholar 

  9. Song IA, Choi HR, Oh TK (2022) Long-term opioid use and mortality in patients with chronic non-cancer pain: ten-year follow-up study in South Korea from 2010 through 2019. EClinicalMedicine 51:101558. https://doi.org/10.1016/j.eclinm.2022.101558

    Article  PubMed  PubMed Central  Google Scholar 

  10. Tang NK, McBeth J, Jordan KP, Blagojevic-Bucknall M, Croft P, Wilkie R (2015) Impact of musculoskeletal pain on insomnia onset: a prospective cohort study. Rheumatology 54(2):248–256

    Article  PubMed  Google Scholar 

  11. Uhlig BL, Sand T, Nilsen T, Mork PJ, Hagen K (2018) Insomnia and risk of chronic musculoskeletal complaints: longitudinal data from the HUNT study, Norway. BMC Musculoskelet Disord 19:1–9

  12. Moradi-Lakeh M, Forouzanfar MH, Vollset SE, El Bcheraoui C, Daoud F, Afshin A et al (2017) Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990–2013: findings from the Global Burden of Disease Study 2013. Ann Rheum Dis 76(8):1365–1373. https://doi.org/10.1136/annrheumdis-2016-210146

    Article  PubMed  Google Scholar 

  13. Savard J, Laroche L, Simard S, Ivers H, Morin CM (2003) Chronic insomnia and immune functioning. Psychosom Med 65(2):211–221. https://doi.org/10.1097/01.psy.0000033126.22740.f3

    Article  PubMed  Google Scholar 

  14. Garbarino S, Lanteri P, Bragazzi NL, Magnavita N, Scoditti E (2021) Role of sleep deprivation in immune-related disease risk and outcomes. Commun Biol 4(1):1304. https://doi.org/10.1038/s42003-021-02825-4

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wu AH, Wang R, Koh W-P, Stanczyk FZ, Lee H-P, Yu MC (2008) Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 29(6):1244–1248

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ta WEHR (1991) The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). J Clin Endocrinol Metab 73(6):1276–1280

    Article  Google Scholar 

  17. Luo J, Zhang Z, Sun H, Song J, Chen X, Huang J et al (2020) Effect of melatonin on T/B cell activation and immune regulation in pinealectomy mice. Life Sci 242:117191

    Article  CAS  PubMed  Google Scholar 

  18. Kakizaki M, Inoue K, Kuriyama S, Sone T, Matsuda-Ohmori K, Nakaya N et al (2008) Sleep duration and the risk of prostate cancer: the Ohsaki cohort study. Br J Cancer 99(1):176–178

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Jiao L, Duan Z, Sangi-Haghpeykar H, Hale L, White D, El-Serag H (2013) Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer 108(1):213–221

    Article  PubMed  PubMed Central  Google Scholar 

  20. Cao J, Eshak ES, Liu K, Muraki I, Cui R, Iso H et al (2019) Sleep duration and risk of breast cancer: the JACC study. Breast Cancer Res Treat 174:219–225

    Article  PubMed  Google Scholar 

  21. Peng TR, Yang LJ, Wu TW, Chao YC (2020) Hypnotics and risk of cancer: a meta-analysis of observational studies. Medicina (Kaunas) 56(10). https://doi.org/10.3390/medicina56100513

  22. Massoco C, Palermo-Neto J (2003) Effects of midazolam on equine innate immune response: a flow cytometric study. Vet Immunol Immunopathol 95(1–2):11–19

    Article  CAS  PubMed  Google Scholar 

  23. Torres SR, Fröde TS, Nardi GM, Vita N, Reeb R, Ferrara P et al (2000) Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. Eur J Pharmacol 408(2):199–211

    Article  CAS  PubMed  Google Scholar 

  24. Yoon K, Shin CM, Han K, Jung JH, Jin EH, Lim JH et al (2023) Risk of cancer in patients with insomnia: nationwide retrospective cohort study (2009–2018). PLoS ONE 18(4):e0284494

  25. Blaess J, Walther J, Petitdemange A, Gottenberg JE, Sibilia J, Arnaud L et al (2020) Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage. Ther Adv Musculoskelet Dis 12:1759720X20959971. https://doi.org/10.1177/1759720X20959971

  26. Hsu CY, Lin MS, Su YJ, Cheng TT, Lin YS, Chen YC et al (2017) Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study. Rheumatology (Oxford) 56(4):620–628. https://doi.org/10.1093/rheumatology/kew457

    Article  PubMed  Google Scholar 

  27. Cronstein BN, Sunkureddi P (2013) Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis. J Clin Rheumatol 19(1):19

    Article  PubMed  PubMed Central  Google Scholar 

  28. Araki Y, Mimura T (2016) The mechanisms underlying chronic inflammation in rheumatoid arthritis from the perspective of the epigenetic landscape. J Immunol Res 2016:6290682. https://doi.org/10.1155/2016/6290682

  29. Nigam M, Mishra AP, Deb VK, Dimri DB, Tiwari V, Bungau SG et al (2023) Evaluation of the association of chronic inflammation and cancer: Insights and implications. Biomed Pharmacother 164:115015. https://doi.org/10.1016/j.biopha.2023.115015

    Article  CAS  PubMed  Google Scholar 

  30. McBeth J, Symmons D, Silman A, Allison T, Webb R, Brammah T et al (2009) Musculoskeletal pain is associated with a long-term increased risk of cancer and cardiovascular-related mortality. Rheumatology 48(1):74–77

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No funding was received for this research.

Author information

Authors and Affiliations

Authors

Contributions

In-Ae Song and Tak Kyu Oh helped with the study's design, conducted data analysis, and wrote the initial manuscript. Hye Yoon Park reviewed the manuscript closely and assisted with data collection. The manuscript was read and approved in its final form by all authors.

Corresponding author

Correspondence to In-Ae Song.

Ethics declarations

Ethical approval

All procedures involving human participants in this study were conducted in adherence to the ethical guidelines set forth by the relevant national and institutional research committees (IRB: X-2105–685-901, Seoul National University Bundang Hospital). Additionally, the 1964 Declaration of Helsinki and any subsequent amendments or comparable ethical standards were utilized.

Consent to participate

For this type of study, formal consent was not required.

Competing interests

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oh, T.K., Park, H.Y. & Song, IA. Insomnia disorder and cancer mortality in South Korea: a secondary analysis of musculoskeletal disease cohort. Sleep Breath (2024). https://doi.org/10.1007/s11325-024-03009-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11325-024-03009-0

Keywords

Navigation